Why Nib shares are on the move after its latest update

Nib shares lift after announcing an approved 2026 health premium change.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in Nib Holdings Ltd (ASX: NHF) are higher in early morning trade after the health insurance provider released an update following market close yesterday.

At the time of writing, the Nib share price is up 3.45% to $6.60.

Here is what investors need to know.

Stethoscope with a piggy bank in the middle.

Image source: Getty Images

Premium increases confirmed for 2026

In an ASX announcement, Nib confirmed that its private health insurance premiums will rise by an average of 5.47%.

The increase follows approval from the Federal Minister for Health and Aged Care.

Management said the changes reflect ongoing cost pressures across the healthcare system. These include higher hospital and medical costs, increased use of services, and broader inflationary impacts.

The company noted that more than half of its policyholders will see increases of $3.80 per week or less.

Chief Executive Officer Ed Close said Nib remains focused on affordability and value, while continuing to manage rising claims costs.

During FY25, the group paid $2.3 billion in claims, an increase of almost 9% on the prior year. The company also recorded more than 400,000 hospital admissions and 4.3 million visits to medical providers.

Momentum and key price levels

Looking at the chart, Nib shares have trended lower since late 2025 after peaking above $8 during the year.

The stock closed at $6.38 on Tuesday and is hovering around $6.60 in early trade. Over the past 12 months, it has traded between $5.82 and $8.26.

On the daily chart, Nib is trading near the lower end of that range. The price is closer to the lower Bollinger Band, suggesting softer short-term momentum.

The relative strength index (RSI) is around 40, placing the stock near oversold territory but not at extreme levels. This suggests selling pressure may be easing, though momentum remains weak.

The $5.80 to $6 zone has acted as support over the past year. On the upside, resistance appears near $7, with further resistance around $7.50 based on prior trading activity.

With the shares closer to support than their 12-month high, the next move may hinge on whether support holds.

What investors will be watching next

Premium adjustments are a normal part of the private health insurance cycle and are closely linked to claims trends and healthcare cost inflation.

While higher premiums can support revenue growth, investors will also be monitoring policyholder retention and membership growth in the months ahead.

Nib is scheduled to release its half-year results on Monday, 23 February. The update will provide further detail on margins, claims trends, and management's outlook for the remainder of the year.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended NIB Holdings. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Half a man's face from the nose up peers over a table.
Healthcare Shares

If I could buy only 1 ASX 200 share right now, it would be…

This stock looks underpriced and oversold to me.

Read more »

woman testing substance in laboratory dish, csl share price
Healthcare Shares

CSL shares slide again in March — but is a comeback brewing?

Brokers remain upbeat and see upside up to 95% for the biotech stock.

Read more »

A female athlete in green spandex leaps from one cliff edge to another representing 3 ASX shares that are destined to rise and be great
Broker Notes

Up 57% since February, why Telix shares could keep leaping higher in 2026

A leading analyst believes investors are undervaluing Telix shares. But why?

Read more »

A woman has a thoughtful look on her face as she studies a fan of Australian 20 dollar bills she is holding on one hand while he rest her other hand on her chin in thought.
Healthcare Shares

Is it time to get greedy with CSL shares?

This ASX healthcare giant is out of favour, but that may be where opportunity starts.

Read more »

Stressed, unhappy, and tired scientist with a headache working on a computer in a lab.
Healthcare Shares

3 ASX 200 healthcare shares at multi-year lows

Does this present a buying opportunity?

Read more »

A white and black clock face is shown with three hands saying Time to Buy reflecting Citi's view that it's time to buy ASX 200 banks
Broker Notes

3 reasons to buy Pro Medicus shares today

Two leading investment analysts believe Pro Medicus shares are primed for a rebound.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Healthcare Shares

Should I invest $10,000 into CSL shares? Yes or no

Is it time to pick up this fallen giant? Let's dig deeper into things.

Read more »

A woman scratches her head, thinking is this a no-brainer?
Healthcare Shares

Does this ASX 200 stock's fall make it a no-brainer buy?

Despite a major transformation, this stock is down more than 20%. Is this an opportunity?

Read more »